PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-11.07%
Both yoy net incomes decline, with MRVL at -34.10%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-0.90%
Negative yoy D&A while MRVL is 0.46%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
96.36%
Some yoy growth while MRVL is negative at -100.03%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
4.55%
SBC growth while MRVL is negative at -12.15%. John Neff would see competitor possibly controlling share issuance more tightly.
-149.76%
Negative yoy working capital usage while MRVL is 20.98%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-73.31%
AR is negative yoy while MRVL is 296.06%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-144.83%
Both reduce yoy inventory, with MRVL at -210.20%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
54.88%
AP growth well above MRVL's 75.34%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-323.08%
Negative yoy usage while MRVL is 24.70%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
100.00%
Lower 'other non-cash' growth vs. MRVL's 273.84%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-53.76%
Both yoy CFO lines are negative, with MRVL at -29.38%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
32.68%
CapEx growth well above MRVL's 45.70%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-1660.00%
Both yoy lines negative, with MRVL at -86.27%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
79.61%
Some yoy expansion while MRVL is negative at -181.93%. John Neff sees competitor possibly refraining from new investments or liquidating existing ones for immediate cash.
60.84%
Proceeds from sales/maturities above 1.5x MRVL's 36.81%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
127.08%
We have mild expansions while MRVL is negative at -404.74%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-50.00%
Both yoy lines negative, with MRVL at -2.20%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
103.94%
We slightly raise equity while MRVL is negative at -92.37%. John Neff sees competitor possibly preserving share count or buying back shares.
No Data
No Data available this quarter, please select a different quarter.